MedTrace Logo

A Phase II Study of an Otic Formulation in Treating Peri-Operative Tube Otorrhea

NCT00578773 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 303

Last updated 2012-12-03

No results posted yet for this study

Summary

The purpose of this study is to determine if an otic formulation is safe and effective in treating peri-operative tube otorrhea.

Conditions

  • Acute Otitis Media

Interventions

DRUG

Moxidex otic solution

4 drops into the infected ear(s) twice daily (morning and evening) for 7 days

DRUG

Moxifloxacin otic solution

4 drops into the infected ear(s) twice daily (morning and evening) for 7 days

DEVICE

Tympanostomy tubes

Tubes surgically inserted through the ear drum for the treatment of recurrent otitis media in children

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Contact Alcon Call Center · 1-888-451-3937

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2009-01-31
Completion
2009-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00578773 on ClinicalTrials.gov